Vay-R®

Helps improve lipid imbalance problems related to being overactive1
Clinically proven to assist in improving emotional regulation and attention1,2
Research proven safe for children2

Assist in improving learning performance

Recent studies have found that ADHD is associated with low levels of Omega-3 in the body. It is believed that supplementing with Omega-3 can be beneficial for children with ADHD. Vay-R® contains krill, is a nutritional supplement targeting children with lipid imbalances. It is a drug-free approach to manage lipid deficiencies and assist in improving learning performance.

Hyperactivity and
lipid imbalance

60% of our brain’s dry weight is made of lipids! Deficiencies in good lipids may result in low attention span and being overactive. The modern diet has resulted in a huge decrease of good lipids, such as Phosphatidylserine (PS) and Omega-3 fatty acids. Researches show that a reduced level of Omega-3 is associated with being overactive and having a low attention span, while dietary intake is one of the factors that may lead to such a reduced level.

A different need, a different way

Vay-R® is a specially formulated lipid composition designed for brain development, so that “healthy” lipids can get across the blood brain barrier.

The nutritional formula of Vay-R® can help manage the lipid imbalances associated with children’s learning performance. Vay-R®’s unique structure is different from ordinary dietary supplements or over-the-counter products in the market. Eicosapentaenoic acid (EPA)-enriched PS-Omega-3 is a composition created through a special patented process to combine Phosphatidylserine (PS) and Omega-3, designed to travel to the brain and provide vital nutrients needed to manage the complex lipid deficiencies associated with learning performance. In a preclinical study comparing PS-Omega-3 to common Omega-3s found in fish oil and PS, our composition was shown to have increased brain bioavailability.1,2 Don’t cheat your brain out of getting what it really needs!

Solid science

Vay-R® has been studied in a double-blind, placebo controlled, randomized clinical study in 162 children with lipid imbalances, and the results were published in a peer-reviewed journal. The study demonstrated the safety of Vay-R® and, in the 15-week open-label extension phase evaluating efficacy, Vay-R® was shown to have effectively reduced activity level and emotional instability, especially in children with more emotional dysregulation. Additionally, in a retrospective study evaluating 518 candidates with lipid deficiencies (average age 11), Vay-R® was shown to assist in improving functioning and reducing emotional dysregulation.3 Our unique PS-Omega-3 structure has shown to significantly increase the bioavailability of Omega-3 in rat brain, compared to using fish oil alone soy-PS and soy-PS combined with fish oil.1,2

Proven safety

Vay-R® has been available for almost 6 years and is both effective and safe. Vay-R®’s unique structure composition was inspired by breast milk, and is a key building block of the brain. It’s been proven safe in children, with virtually no side effects.2

Is Vay-R® right for my child?

Each child is unique, but if the child appears to have the following “Emotional Dysregulation” symptoms, Vay-R® is relatively suitable for them. These behaviors can even be categorized as internal and external. Take a look below for some examples:

External emotional dysregulation behaviors

  • Experiences an “emotional roller coaster”
  • Disrupts class
  • Interrupts conversations
  • Gets into fights
  • Has outbursts

Internal emotional dysregulation behaviors

  • Cannot calm down
  • Has trouble falling asleep
  • Is antisocial
  • Experiences mood swings
  • Does not think before acting

Good things take time

PS-Omega-3 works as a building block in the brain, so consistent daily use is critical. Since lipid levels vary by individual, it can take up to 30 to 90 days to build up in the system. It is important to give Vay-R® the time it needs to be effective.
References
1. Manor, I., et al. "The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension." European Psychiatry27.5 (2012): 335-342.

2. Manor, I., et al. "Safety of phosphatidylserine containing omega3 fatty acids in ADHD children: a double-blind placebo-controlled trial followed by an open-label extension." European Psychiatry 28.6 (2013): 386-391.

3. Ivanir, E., et al. “Short & Long-Term Impact of a Nutritional Approach for the Management of ADHD: A Real World Study.